Showing results (121-130 of 23,509) with videos related to

Sort By:
Pageof 2,351
The Journal of Pharmacology and Experimental Therapeutics|September 10, 2010
Pharmacological chaperones restore function to MC4R mutants responsible for severe early-onset obesityPatricia René, Christian Le Gouill, Irina D Pogozheva, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 10, 2010
Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activityAlessandro Pini, Ronen Shemesh, Chrishan S Samuel, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 10, 2010
A transmembrane amino acid in the GABAA receptor β2 subunit critical for the actions of alcohols and anestheticsMandy L McCracken, Cecilia M Borghese, James R Trudell, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 2010
Bronchodilator activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a potent, long-acting, and selective muscarinic M3 receptor antagonistG Villetti, F Pastore, M Bergamaschi, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 3, 2010
Inhaled anesthetic responses of recombinant receptors and knockin mice harboring α2(S270H/L277A) GABA(A) receptor subunits that are resistant to isofluraneD F Werner, A Swihart, V Rau, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 23, 2010
Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in miceW E Fantegrossi, J Simoneau, M S Cohen, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 25, 2010
H3 receptors and pain modulation: peripheral, spinal, and brain interactionsLindsay B Hough, Frank L Rice
The Journal of Pharmacology and Experimental Therapeutics|September 25, 2010
Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimer's diseaseJorge D Brioni, Tim A Esbenshade, Tiffany Runyan Garrison, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 25, 2010
The novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization propertiesBarbara J Caldarone, Neil E Paterson, Jia Zhou, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 18, 2010
Pretreatment of Guinea pigs with galantamine prevents immediate and delayed effects of soman on inhibitory synaptic transmission in the hippocampusElena A Alexandrova, Yasco Aracava, Edna F R Pereira, et al.
Pageof 2,351